Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 04, 2023

SELL
$418.69 - $503.0 $1,256 - $1,509
-3 Reduced 10.71%
25 $11,000
Q4 2022

Feb 03, 2023

SELL
$351.71 - $456.01 $66,121 - $85,729
-188 Reduced 87.04%
28 $11,000
Q3 2022

Nov 02, 2022

BUY
$412.59 - $563.26 $69,315 - $94,627
168 Added 350.0%
216 $90,000
Q2 2022

Jul 18, 2022

BUY
$463.67 - $597.16 $22,256 - $28,663
48 New
48 $24,000
Q4 2020

Feb 04, 2021

SELL
$510.68 - $643.45 $24,512 - $30,885
-48 Closed
0 $0
Q3 2020

Oct 26, 2020

SELL
$454.43 - $535.6 $5,453 - $6,427
-12 Reduced 20.0%
48 $25,000
Q2 2020

Jul 06, 2020

SELL
$334.87 - $493.06 $6,697 - $9,861
-20 Reduced 25.0%
60 $27,000
Q1 2020

Apr 13, 2020

BUY
$320.01 - $409.07 $1,920 - $2,454
6 Added 8.11%
80 $28,000
Q4 2019

Feb 05, 2020

BUY
$319.73 - $374.2 $23,660 - $27,690
74 New
74 $27,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.43B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.